ARCHIVES

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

Cancer Incidence Rates Climb In HIV-Positive Female Populations

April 27, 2012

A Conversation with MSKCC’s José Baselga: We Need to Increase Our Reach

September 27, 2013

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980